InsidersTradesSigma
Track the 上海谊众 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 上海谊众 has published 11 public disclosures. Market capitalisation: €8.4bn. The latest transaction was filed on 30 July 2026 (Purchase). Among the most active insiders: 刘刚. Every trade is accessible without an account.
11
Insider Decl.
n/a
Thresholds
€14,230
1 ops.
Buy Volume
€17m
10 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,809 of 29,063 companies
55.1
score / 100
Value34
Quality76
FCF yld-1.8%
Earn yld0.8%
EV/EBITDA·
ROE4.8%
Gross mgn83%
Net mgn20%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 July 2026
Declarations11 total
11 of 11 declarations
Acerca de 上海谊众
Shanghai Yizhong es una empresa que opera en el sector de la salud y farmacéutico, especializada en la investigación y el desarrollo de productos farmacéuticos. Cotiza en el mercado XSHG.